Juan Luis Paris Wins Málaga Research Prize for Nanomedicine Work
Researcher Juan Luis Paris has won the 2026 Málaga Research Prize in the Science category, awarded by the Fundación Málaga. The jury selected his project titled Diseño, preparación y evaluación de nanopartículas para la mejora del diagnóstico y terapia de enfermedades alérgicas, which applies nanomedicine to develop new tools to advance the knowledge, diagnosis, and treatment of these pathologies.
Paris belongs to the Allergic Diseases to Drugs and Allergens group at Ibima Plataforma Bionand. The award highlights his ongoing efforts to translate advances in nanotechnology into the biomedical field, especially for the study of allergic diseases. The researcher completed his doctoral thesis at the Universidad Complutense de Madrid and has developed his scientific activity at international institutions including the Boston Children’s Hospital, the University of Oxford, the International Iberian Nanotechnology Laboratory, and Queen’s University Belfast.
Building on European Research Council Funding
The 2026 science prize follows another major milestone for Paris and his research group. In September 2025, he secured an ERC Starting Grant worth 1.7 million euros from the European Research Council. That grant marked the second ERC secured by Ibima, reinforcing the capacity of the institute to develop high-impact scientific projects.
While his earlier career touched on cancer research, post-surgical pain, infections, gene therapy, and bone regeneration, Paris now concentrates his laboratory work on allergic diseases. His research combines nanotechnology, biomedicine, and clinical investigation with the objective of seeking new solutions for allergic diseases.
Frequently Asked Questions About the Research Award
What specific project earned Juan Luis Paris the 2026 Málaga Research Prize?
The Fundación Málaga recognized his research project titled Diseño, preparación y evaluación de nanopartículas para la mejora del diagnóstico y terapia de enfermedades alérgicas.
Which institution does Juan Luis Paris represent in Málaga?
He conducts his research as part of the Allergic Diseases to Drugs and Allergens group at Ibima Plataforma Bionand.
What prior financial backing did his research receive?
In September 2025, Paris received a 1.7 million euro ERC Starting Grant from the European Research Council to support his innovative laboratory work.
